Episode 35: Biotech's October slump, the precise cost of precision, and breaking postpartum silence

Why are biotech stocks in the dumps? Is the latest in cancer care overhyped? And what does "folie à deux" mean?

Om Podcasten

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.